Roman Praschberger
Research Subjects
Roman Praschberger has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Patrik Verstreken
VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium; KU Leuven, Department of Neurosciences, Leuven Brain Institute, 3000 Leuven, Belgium
4 shared publications - Antonio Ortega
VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium
2 shared publications Dries Chabot
VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium
2 shared publications- El-Sayed Baz
Laboratory of Behavioral and Developmental Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium
2 shared publications Jeevanjot Singh
VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium
2 shared publicationsJesse Davis
KU Leuven, Department of Computer Science, Leuven, Belgium
2 shared publications
Latest Publications
- 6 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (45)
Common transcriptional changes in the brain during hibernation and Alzheimer’s disease
Hibernation demands rapid brain adaptations, involving cycles of reduced metabolic rate during torpor, followed by brief periods of arousal. Previous studies show hibernation induces a drastic increase in Tau hyperphosphorylation, but a mechanistic connection to disease remains unclear. Using single-nucleus RNA sequencing on hippocampi of golden hamsters, we unveil large transcriptional shifts across the hibernation cycle in all cell types, especially glia. Common transcriptional changes in mitochondrial and ribosomal genes are observed in all different cell types. In addition, hibernation triggers an inflammatory-like response in microglia that in part resembles cell states observed in Alzheimer’s disease, but here in the absence of Aβ-accumulation and neurodegeneration. These findings reveal brain transformations that might help preserve vital functions under extreme conditions and they suggest that early cellular changes in AD may be a natural adaptive process.
- 6 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (45)
Common transcriptional changes in the brain during hibernation and Alzheimer’s disease
Hibernation demands rapid brain adaptations, involving cycles of reduced metabolic rate during torpor, followed by brief periods of arousal. Previous studies show hibernation induces a drastic increase in Tau hyperphosphorylation, but a mechanistic connection to disease remains unclear. Using single-nucleus RNA sequencing on hippocampi of golden hamsters, we unveil large transcriptional shifts across the hibernation cycle in all cell types, especially glia. Common transcriptional changes in mitochondrial and ribosomal genes are observed in all different cell types. In addition, hibernation triggers an inflammatory-like response in microglia that in part resembles cell states observed in Alzheimer’s disease, but here in the absence of Aβ-accumulation and neurodegeneration. These findings reveal brain transformations that might help preserve vital functions under extreme conditions and they suggest that early cellular changes in AD may be a natural adaptive process.
- Open Access
- 17 April 2026
- Published by Elsevier in Cell Reports Methods
- Vol. 6 (5) , 101409
Light-inducible FLPase reconstitution enables temporal control of gene expression in Drosophila melanogaster
- 17 April 2026
- Published by Elsevier in Cell Reports Methods
- Vol. 6 (5) , 101409
Open AccessLight-inducible FLPase reconstitution enables temporal control of gene expression in Drosophila melanogaster
- Open Access
- 10 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Behavioral screening defines the molecular Parkinsonism-related subgroups in Drosophila
Parkinson’s disease (PD) and related familial Parkinsonism are defined by motor dysfunction, but the specific upstream molecular causes of these clinical symptoms can vary widely. We hypothesize that these causes converge onto a limited number of core cellular pathways. To investigate this, we created a collection of 24 genetically well-controlled Drosophila models of familial forms of PD and related mono-genic forms of Parkinsonism. Using unbiased behavioral screening and machine learning we identify clusters of mutants that converge on (1) mitochondrial function; (2) retromer/vesicle trafficking and proteostasis/autophagy. Genes within each cluster have a similar genetic interaction profile and compounds that target specific molecular pathways ameliorate dopaminergic neuron dysfunction in a cluster-specific manner. Together, our data indicate that familial PD and related forms of Parkinsonism may fall into two broad functional groups, and may inform further work toward targeted biomarker discovery and therapeutic development.
- 10 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessBehavioral screening defines the molecular Parkinsonism-related subgroups in Drosophila
Parkinson’s disease (PD) and related familial Parkinsonism are defined by motor dysfunction, but the specific upstream molecular causes of these clinical symptoms can vary widely. We hypothesize that these causes converge onto a limited number of core cellular pathways. To investigate this, we created a collection of 24 genetically well-controlled Drosophila models of familial forms of PD and related mono-genic forms of Parkinsonism. Using unbiased behavioral screening and machine learning we identify clusters of mutants that converge on (1) mitochondrial function; (2) retromer/vesicle trafficking and proteostasis/autophagy. Genes within each cluster have a similar genetic interaction profile and compounds that target specific molecular pathways ameliorate dopaminergic neuron dysfunction in a cluster-specific manner. Together, our data indicate that familial PD and related forms of Parkinsonism may fall into two broad functional groups, and may inform further work toward targeted biomarker discovery and therapeutic development.
- Open Access
Behavioral screening defines three molecular Parkinsonism subgroups in Drosophila
Parkinsonism is defined by motor dysfunction, but the specific upstream molecular causes of these clinical symptoms can vary widely. We hypothesize that these causes converge onto a limited number of core cellular pathways. To investigate this, we created a new collection of 24 genetically very well-controlled animal models of familial forms of parkinsonism. Using unbiased behavioral screening and machine learning we identified three clusters of mutants that converge on (1) mitochondrial function; (2) retromer/vesicle trafficking; and (3) proteostasis/autophagy. Genes within each cluster have a similar genetic interaction profile and compounds that target specific molecular pathways ameliorate dopaminergic neuron dysfunction in a cluster-specific manner. This suggests that familial parkinsonism can be stratified into three broad functional groups and our findings pave the way for targeted biomarker discovery and drug development.
Open AccessBehavioral screening defines three molecular Parkinsonism subgroups in Drosophila
Parkinsonism is defined by motor dysfunction, but the specific upstream molecular causes of these clinical symptoms can vary widely. We hypothesize that these causes converge onto a limited number of core cellular pathways. To investigate this, we created a new collection of 24 genetically very well-controlled animal models of familial forms of parkinsonism. Using unbiased behavioral screening and machine learning we identified three clusters of mutants that converge on (1) mitochondrial function; (2) retromer/vesicle trafficking; and (3) proteostasis/autophagy. Genes within each cluster have a similar genetic interaction profile and compounds that target specific molecular pathways ameliorate dopaminergic neuron dysfunction in a cluster-specific manner. This suggests that familial parkinsonism can be stratified into three broad functional groups and our findings pave the way for targeted biomarker discovery and drug development.